Login

Thoughts on gaming in crypto, NFTs, work-life balance and more|Ramnik Arora,Head of Product,FTX 00:10:00

Share On Facebook Share On Twitter

Founder of Toy Ventures. Attended Stanford University.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Assessing India's Budget: Impact, Reforms, and Market Outlook | A. Balasubramanian, CEO , Aditya Birla Sun Life AMC Limited.
00:10:00
Developing next generation peptide therapeutics for obesity and liver disease|Vipin K Garg,President,Altimmune Inc
00:10:00
Retirement Revealed: Insights from Barry LaValley | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
"Aamal Company's CEO, Mr. Rashid Al Mansoori, discusses the company's innovative strategies for sustainable growth and community development on Qatar Television."| Mr. Rashid Al Mansoori CEO of Aamal Company
00:00:00
Michael Castagna, PharmD Chief Executive Officer, Maternus Kliniken
00:10:00
Chairman and CEO of Iwatani Corporation, Mr. Akiji Makino, attends the 4th Hydrogen Energy Ministerial Meeting.
00:10:00
David Bromelkamp at the 2013 Fi360 INSIGHTS Conference: Championing Fiduciary Excellence | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:10:00
"Exploring Sustainable Real Estate Strategies with Boston Properties' Sustainability Manager, Ben Myers"|Senior Vice President,Boston Properties Inc
00:10:00
A snapshot of the stocks on the move, featuring BluGlass Limited, Vection Technologies Ltd (ASX:VR1), and Lake Resources, highlights significant market activity and trends.
00:00:00
Oncimmune's strategic pivot aims for robust growth in 2024 - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:10:00
Insights on Upstream Consolidation and Redetermination Trends from Keith Buchanan"
00:10:00
Acushnet Holdings Chairman Gene Yoon on Revitalizing FILA and Leading the Brand’s Success | Gene Yoon, Chairman , Acushnet Holding.

© 2017 - Neuhu+